Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/19/2013US20130337058 Micronized Tanaproget and Compositions Containing Same
12/19/2013US20130337055 Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection
12/19/2013US20130337054 Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibrinolytic or hemostatic agent
12/19/2013US20130337053 Novel formulations and methods
12/19/2013US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication
12/19/2013US20130337051 Advanced active liposomal loading of poorly water-soluble substances
12/19/2013US20130337048 Method and compositions for treating hiv infection
12/19/2013US20130337047 Compositions for treating oral and periodontal infections
12/19/2013US20130337046 Methods for Improved Delivery of Aminothiols, Dimers of Aminothiols, and Heterodimers Composed of Aminothiols
12/19/2013US20130337042 Use of PVP-Iodine Liposomes for Treatment of Herpes
12/19/2013US20130337041 Charged phospholipid compositions and methods for their use
12/19/2013US20130337040 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer
12/19/2013US20130337039 Internalizing ErBB2 Antibodies
12/19/2013US20130337033 Nitric oxide-releasing compositions and methods
12/19/2013US20130337032 Topical Patch For Pain Relief Using Cooling Agent
12/19/2013US20130337031 Topical formulations, systems and methods
12/19/2013US20130337019 Compositions containing quaternary ammonium compounds
12/19/2013US20130337016 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
12/19/2013US20130337015 C-Met Modulator Pharmaceutical Compositions
12/19/2013US20130336993 Modulation of the Immune Response
12/19/2013US20130336990 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
12/19/2013US20130336988 Methods for treating early stage or mild neurological disorders
12/19/2013US20130336986 Kinases as targets for anti-diabetic therapy
12/19/2013US20130336969 Use of olfactomedin-4 protein (olfm4) in colorectal cancer diagnosis
12/19/2013US20130336966 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections
12/19/2013US20130336965 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
12/19/2013US20130336962 Aziridine bisphenol ethers and related compounds and methods for their use
12/19/2013US20130336952 Pharmaceutical compositions and related methods
12/19/2013US20130336950 Material combination for treating inflammatory or infectious diseases
12/19/2013US20130336949 Tetrazole compounds for reducing uric acid
12/19/2013US20130336945 Stable compositions of tetrahydrobiopterin
12/19/2013US20130336941 Long lasting absorption of flavonoids
12/19/2013US20130336921 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336920 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336919 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336918 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336917 Polymeric treatment compositions
12/19/2013US20130336903 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using
12/19/2013US20130336902 Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using
12/19/2013US20130336899 Antimicrobial formulations that aid in wound healing
12/19/2013US20130336886 Tumor specific antibodies and uses therefor
12/19/2013US20130333831 Films and Drug Delivery Systems Made Therefrom
12/19/2013DE102012012178A1 Aqueous composition useful e.g. as bactericidal disinfecting agent for skin surface, comprises aliphatic alcohol with functional hydroxy group, organic and inorganic peroxide, di- or polyhydroxy compound, and viscosity-increasing thickener
12/19/2013CA2877715A1 Topical ophthalmological pharmaceutical composition containing axitinib
12/19/2013CA2877710A1 Topical ophthalmological pharmaceutical composition containing pazopanib
12/19/2013CA2877678A1 Topical ophthalmological pharmaceutical composition containing cediranib
12/19/2013CA2876902A1 Compositions and methods for transmucosal absorption
12/19/2013CA2876741A1 Forms of vilazodone and processes for the preparation thereof
12/19/2013CA2876739A1 Pharmaceutical composition containing phosphate binding polymer
12/19/2013CA2876573A1 Heteroarylcarboxylic acid ester derivative
12/19/2013CA2876540A1 A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
12/19/2013CA2876539A1 Multicomponent crystals comprising dasatinib and selected co-crystal formers
12/19/2013CA2876536A1 Pharmaceutical composition for the regeneration of the liver
12/19/2013CA2876403A1 Desethylamiodarone compositions
12/19/2013CA2876382A1 Piperidinylpyrazolopyridine derivative
12/19/2013CA2876371A1 Prophylactic and/or therapeutic agent for mild cognitive impairment
12/19/2013CA2876311A1 Topical ophthalmological pharmaceutical composition containing sunitinib
12/19/2013CA2876306A1 Deuterated derivatives of ruxolitinib
12/19/2013CA2876299A1 Chemoprevention of colorectal cancer
12/19/2013CA2876286A1 Nutritional product
12/19/2013CA2876283A1 Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
12/19/2013CA2876253A1 Heteroaromatic methyl cyclic amine derivative
12/19/2013CA2876249A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013CA2876203A1 Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
12/19/2013CA2876177A1 Treatment and prevention of cardiovascular disease and thrombosis
12/19/2013CA2876074A1 N-substituted second generation derivatives of antifungal antibiotic amphotericin b and methods of their preparation and application
12/19/2013CA2876070A1 Method of preparing a composition based on hyaluronic acid
12/19/2013CA2875824A1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
12/19/2013CA2875802A1 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013CA2875541A1 Combination of therapeutic agents for treating hcv infection
12/19/2013CA2875504A1 Feijoa fruit extract
12/19/2013CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/19/2013CA2875342A1 Desfesoterodine salts
12/19/2013CA2875198A1 Compounds for treating inflammation and pain
12/19/2013CA2875094A1 Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
12/19/2013CA2874988A1 Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
12/19/2013CA2874953A1 Pyridinone and pyridazinone derivatives
12/19/2013CA2840372A1 Method for producing powders for inhalation
12/18/2013EP2674498A1 Asymmetric hydration of 4-hydroxystyrene derivatives employing decarboxylases
12/18/2013EP2674493A1 RNAi-mediated inhibition of histamine receptor H1-related conditions
12/18/2013EP2674436A1 Water-soluble benzoazepine compound and its pharmaceutical composition
12/18/2013EP2674434A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators
12/18/2013EP2674433A1 LIMK2 inhibitors, compositions comprising them and methods of their use
12/18/2013EP2674432A1 New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds
12/18/2013EP2674430A1 Amino group-containing pyrrolidinone derivative
12/18/2013EP2674428A1 Modulators of ATP-binding cassette transporters
12/18/2013EP2674423A1 Pyrazole derivative and pest control agent
12/18/2013EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation
12/18/2013EP2674415A1 Homo- and hetero-polyamino-acid derivatives of fullerene c60, method for producing same, and pharmaceutical compositions based on said derivatives
12/18/2013EP2674166A1 Use of erythropoietin (EPO) for the local treatment of cancer treatment-associated osteo-necrosis of the jaw
12/18/2013EP2674164A1 Kallikrein inhibitors and uses thereof
12/18/2013EP2674161A1 FMO3 inhibitors for treating pain
12/18/2013EP2674160A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
12/18/2013EP2674159A1 Pharmaceutical compound for liver regeneration
12/18/2013EP2674158A1 Treatment and prevention of cardiac arrhythmias
12/18/2013EP2674157A1 Therapeutic agent for diastolic congestive heart failure
12/18/2013EP2674156A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
12/18/2013EP2674155A1 Association of resveratrol and carboxymethylglucan
12/18/2013EP2674154A2 Sildenafil-free base-containing film preparation and method for producing same
12/18/2013EP2674153A1 Bendroflumethiazide-containing controlled release pharmaceutical formulations
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 7860